ALEUP — Europlasma SA Cashflow Statement
0.000.00%
- €0.22m
- €10.99m
- €42.45m
Annual cashflow statement for Europlasma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -10.6 | -12.7 | -15.8 | -14.7 | -15.9 |
Depreciation | |||||
Non-Cash Items | -1.52 | 0.835 | -1.92 | -3.1 | -7.46 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.85 | -9.05 | 6.29 | 0.559 | -0.532 |
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -12.1 | -18.2 | -5.14 | -9.97 | -10.9 |
Capital Expenditures | -4.77 | -5.43 | -2.9 | -1.73 | -1.52 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.985 | -0.272 | -1.25 | 0.781 | -0.574 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5.76 | -5.7 | -4.16 | -0.953 | -2.09 |
Financing Cash Flow Items | -0.222 | -0.12 | -5.34 | -0.469 | 4.42 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 19.3 | 22.1 | 9.23 | 9.67 | 13.6 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.44 | -1.68 | -0.062 | -1.25 | 0.587 |